-
1
-
-
0032405602
-
Acute promyelocyte leukaemia: A curable disease
-
Lo Coco F et al. Acute promyelocyte leukaemia: a curable disease. Leukemia 1998; 12: 1866-1880.
-
(1998)
Leukemia
, vol.12
, pp. 1866-1880
-
-
Lo Coco, F.1
-
2
-
-
0037409182
-
The molecular pathogenesis of acute promyelocytic leukaemia: Implications for the clinical management of the disease
-
Mistry AR et al. The molecular pathogenesis of acute promyelocytic leukaemia: implications for the clinical management of the disease. Blood Rev 2003; 17: 71-97.
-
(2003)
Blood Rev
, vol.17
, pp. 71-97
-
-
Mistry, A.R.1
-
3
-
-
0036464594
-
Acute promyelocytic leukaemia: Evolving therapeutic strategies
-
Tallman MS et al. Acute promyelocytic leukaemia: evolving therapeutic strategies. Blood 2002; 99: 759-767.
-
(2002)
Blood
, vol.99
, pp. 759-767
-
-
Tallman, M.S.1
-
4
-
-
0030010877
-
Cell differentiation in acute myeloid leukaemia
-
Olsson I et al. Cell differentiation in acute myeloid leukaemia. Eur J Haematol 1996; 57: 1-16.
-
(1996)
Eur J Haematol
, vol.57
, pp. 1-16
-
-
Olsson, I.1
-
5
-
-
0033890197
-
Long-term follow-up confirms the benefit of all- trans retinoic acid in acute promyelocytic leukaemia
-
Fenaux P et al. Long-term follow-up confirms the benefit of all- trans retinoic acid in acute promyelocytic leukaemia. Leukemia 2000; 14: 1371-1377.
-
(2000)
Leukemia
, vol.14
, pp. 1371-1377
-
-
Fenaux, P.1
-
6
-
-
0035969111
-
Pathways of retinoic acid or arsenic trioxideinduced PML/RARα catabolism, role of oncogene degradation in disease remission
-
Zhu J et al. Pathways of retinoic acid or arsenic trioxideinduced PML/RARα catabolism, role of oncogene degradation in disease remission. Oncogene 2001; 20: 7257-7265.
-
(2001)
Oncogene
, vol.20
, pp. 7257-7265
-
-
Zhu, J.1
-
7
-
-
0029940731
-
Infrequent alterations of the RAR alpha gene in acute myelogenous leukemias, retinoic acid-resistant acute promyelocytic leukemias, myelodysplastic syndromes, and cell lines
-
Morosetti R et al. Infrequent alterations of the RAR alpha gene in acute myelogenous leukemias, retinoic acid-resistant acute promyelocytic leukemias, myelodysplastic syndromes, and cell lines. Blood 1996; 87: 4399-4403.
-
(1996)
Blood
, vol.87
, pp. 4399-4403
-
-
Morosetti, R.1
-
8
-
-
0034962358
-
Novel mutation in the PML/RARα chimeric gene exhibits dramatically decreased ligand-binding activity and confers acquired resistance to retinoic acid in acute promyelocytic leukaemia
-
Takayama N et al. Novel mutation in the PML/RARα chimeric gene exhibits dramatically decreased ligand-binding activity and confers acquired resistance to retinoic acid in acute promyelocytic leukaemia. Exp Hematol 2001; 29: 864-872.
-
(2001)
Exp Hematol
, vol.29
, pp. 864-872
-
-
Takayama, N.1
-
9
-
-
0037082488
-
Frequent mutations in the ligand-binding domain of PML-RARalpha after multiple relapse of acute promyelocytic leukaemia: Analysis for functional relationship to response to all-trans retinoic acid and histone deacetylase inhibitors in vitro and in vivo
-
Zhou DC et al. Frequent mutations in the ligand-binding domain of PML-RARalpha after multiple relapse of acute promyelocytic leukaemia: analysis for functional relationship to response to all-trans retinoic acid and histone deacetylase inhibitors in vitro and in vivo. Blood 2002; 99: 1356-1363.
-
(2002)
Blood
, vol.99
, pp. 1356-1363
-
-
Zhou, D.C.1
-
10
-
-
33646479031
-
Relapse of acute promyelocytic leukemia with PML-RARalpha mutant subclones independent of proximate all-trans retinoic acid selection pressure
-
Gallagher RE et al. Relapse of acute promyelocytic leukemia with PML-RARalpha mutant subclones independent of proximate all-trans retinoic acid selection pressure. Leukemia 2006; 20: 556-562.
-
(2006)
Leukemia
, vol.20
, pp. 556-562
-
-
Gallagher, R.E.1
-
11
-
-
0033668199
-
Induction of differentiation and apoptosis: A possible strategy in the treatment of adult acute myelogenous leukaemia
-
Bruserud O et al. Induction of differentiation and apoptosis: a possible strategy in the treatment of adult acute myelogenous leukaemia. Oncologist 2000; 5: 454-462.
-
(2000)
Oncologist
, vol.5
, pp. 454-462
-
-
Bruserud, O.1
-
12
-
-
3242772761
-
Auranofin induces apoptosis and when combined with retinoic acid enhances differentiation of acute promyelocytic leukaemia cells in vitro
-
Kim IS et al. Auranofin induces apoptosis and when combined with retinoic acid enhances differentiation of acute promyelocytic leukaemia cells in vitro. Br J Pharmacol 2004; 142: 749-755.
-
(2004)
Br J Pharmacol
, vol.142
, pp. 749-755
-
-
Kim, I.S.1
-
13
-
-
0028229587
-
Cell differentiation-inducing diterpenes from Andrographis paniculata Nees
-
Matsuda T et al. Cell differentiation-inducing diterpenes from Andrographis paniculata Nees. Chem Pharm Bull Tokyo 1994; 42: 1216-1225.
-
(1994)
Chem Pharm Bull Tokyo
, vol.42
, pp. 1216-1225
-
-
Matsuda, T.1
-
14
-
-
0027295862
-
Immunostimulant agents from Andrographis paniculata
-
Puri A et al. Immunostimulant agents from Andrographis paniculata. J Nat Prod 1993; 56: 995-999.
-
(1993)
J Nat Prod
, vol.56
, pp. 995-999
-
-
Puri, A.1
-
15
-
-
33644761594
-
Potential of AG in the treatment of breast cancer
-
Stanslas J et al. Potential of AG in the treatment of breast cancer. Eur. J. Cancer Suppl 2001; 6(37): 169.
-
(2001)
Eur. J. Cancer Suppl
, vol.6
, Issue.37
, pp. 169
-
-
Stanslas, J.1
-
16
-
-
2342550564
-
Anticancer and immunostimulatory compounds from Andrographis paniculata
-
Kumar AR et al. Anticancer and immunostimulatory compounds from Andrographis paniculata. J Ethnopharmacol 2004; 92: 291-295.
-
(2004)
J Ethnopharmacol
, vol.92
, pp. 291-295
-
-
Kumar, A.R.1
-
17
-
-
30844438519
-
Andrographolide isolated from Andrographis paniculata induces cell cycle arrest and rnitochondrial-mediated apoptosis in human leukemic HL-60 cells
-
Cheung HY et al. Andrographolide isolated from Andrographis paniculata induces cell cycle arrest and rnitochondrial-mediated apoptosis in human leukemic HL-60 cells. Planta Med 2005; 71(12): 1106-1111.
-
(2005)
Planta Med
, vol.71
, Issue.12
, pp. 1106-1111
-
-
Cheung, H.Y.1
-
18
-
-
33744915312
-
Critical role of Bcl-2 family members in andrographolide-induced apoptosis in human cancer cells
-
Zhou J et al. Critical role of Bcl-2 family members in andrographolide-induced apoptosis in human cancer cells. Biochem Pharmacol 2006; 72: 132-144.
-
(2006)
Biochem Pharmacol
, vol.72
, pp. 132-144
-
-
Zhou, J.1
-
19
-
-
34250825923
-
Andrographolide induces cell cycle arrest at G2/M phase and cell death in HepG2 via alteration of reactive oxygen species
-
Li J et al. Andrographolide induces cell cycle arrest at G2/M phase and cell death in HepG2 via alteration of reactive oxygen species. Eur J Pharmacol 2007; 568: 31-44.
-
(2007)
Eur J Pharmacol
, vol.568
, pp. 31-44
-
-
Li, J.1
-
20
-
-
0026013478
-
NB4, a maturation inducible cell line with t (15; 17) marker isolated from a human acute promyelocytic leukaemia (M3)
-
Lanotte M et al. NB4, a maturation inducible cell line with t (15; 17) marker isolated from a human acute promyelocytic leukaemia (M3). Blood 1991; 77: 1080-1086.
-
(1991)
Blood
, vol.77
, pp. 1080-1086
-
-
Lanotte, M.1
-
21
-
-
0033962657
-
A mutated PML/RARα found in the retinoid maturation resistant NB4 subclone, NB4-R2, blocks RARα and wild-type PML/RARα transcriptional activities
-
Duprez E et al. A mutated PML/RARα found in the retinoid maturation resistant NB4 subclone, NB4-R2, blocks RARα and wild-type PML/RARα transcriptional activities. Leukemia 2000; 14: 255-261.
-
(2000)
Leukemia
, vol.14
, pp. 255-261
-
-
Duprez, E.1
-
22
-
-
0023835276
-
HL-60 cell line was derived from a patient with FAB-M2 and not FAB-M3
-
Dalton WT et al. HL-60 cell line was derived from a patient with FAB-M2 and not FAB-M3. Blood 1988; 71: 242-247.
-
(1988)
Blood
, vol.71
, pp. 242-247
-
-
Dalton, W.T.1
-
23
-
-
0030031227
-
Myeloid differentiation and retinoblastoma phosphorylation changes in HL-60 cells induced by retinoic acid receptor- and retinoid X receptor-selective retinoic acid analogs
-
Brooks SC et al. Myeloid differentiation and retinoblastoma phosphorylation changes in HL-60 cells induced by retinoic acid receptor- and retinoid X receptor-selective retinoic acid analogs. Blood 1996; 87: 227-237.
-
(1996)
Blood
, vol.87
, pp. 227-237
-
-
Brooks, S.C.1
-
24
-
-
0035863395
-
Granulocytic differentiation of human NB4 promyelocytic leukaemia cells induced by all-trans retinoic acid metabolites
-
Idres N et al. Granulocytic differentiation of human NB4 promyelocytic leukaemia cells induced by all-trans retinoic acid metabolites. Cancer Res 2001; 61: 700-705.
-
(2001)
Cancer Res
, vol.61
, pp. 700-705
-
-
Idres, N.1
-
25
-
-
0021061819
-
Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays
-
Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65: 55-63.
-
(1983)
J Immunol Methods
, vol.65
, pp. 55-63
-
-
Mosmann, T.1
-
26
-
-
0028868608
-
Synthesis and characterization of a highly potent and effective antagonist of retinoic acid receptor
-
Johnson AT et al. Synthesis and characterization of a highly potent and effective antagonist of retinoic acid receptor. J Med Chem 1995; 38: 4764-4767.
-
(1995)
J Med Chem
, vol.38
, pp. 4764-4767
-
-
Johnson, A.T.1
-
27
-
-
19344375948
-
Anti-proliferative and apoptotic effects of celecoxib on human chronic myeloid leukaemia in vitro
-
Subhashini J et al. Anti-proliferative and apoptotic effects of celecoxib on human chronic myeloid leukaemia in vitro. Cancer Lett 2005; 224: 31-43.
-
(2005)
Cancer Lett
, vol.224
, pp. 31-43
-
-
Subhashini, J.1
-
28
-
-
4644293319
-
Gemtuzumab ozogamicin (Mylotarg) as a single agent for molecularly relapsed acute promyelocytic leukemia
-
Lo Coco F et al. Gemtuzumab ozogamicin (Mylotarg) as a single agent for molecularly relapsed acute promyelocytic leukemia. Blood 2004; 104: 1995-1999.
-
(2004)
Blood
, vol.104
, pp. 1995-1999
-
-
Lo Coco, F.1
-
29
-
-
33847234222
-
Treatment of relapsed or refractory acute promyelocytic leukemia
-
Tallman MS. Treatment of relapsed or refractory acute promyelocytic leukemia. Best Pract Res Clin Haematol 2007; 20(1): 57-65.
-
(2007)
Best Pract Res Clin Haematol
, vol.20
, Issue.1
, pp. 57-65
-
-
Tallman, M.S.1
-
30
-
-
0029942879
-
Accelerated degradation of PML-retinoic acid receptor (PML-RARA) oncoprotein by all-transretinoic acid in acute promyelocytic leukaemia: Possible role of the proteasome pathway
-
Yoshida H et al. Accelerated degradation of PML-retinoic acid receptor (PML-RARA) oncoprotein by all-transretinoic acid in acute promyelocytic leukaemia: possible role of the proteasome pathway. Cancer Res 1996; 56: 2945-2948.
-
(1996)
Cancer Res
, vol.56
, pp. 2945-2948
-
-
Yoshida, H.1
-
31
-
-
15844384344
-
AGN193109 is a highly effective antagonist of retinoid action in human ectocervical epithelial cells
-
Agarwal C et al. AGN193109 is a highly effective antagonist of retinoid action in human ectocervical epithelial cells. J Biol Chem 1996; 271: 12209-12212.
-
(1996)
J Biol Chem
, vol.271
, pp. 12209-12212
-
-
Agarwal, C.1
-
32
-
-
0029562554
-
The RXR heterodimers and orphan receptors
-
Mangelsdorf DJ, Evans RM. The RXR heterodimers and orphan receptors. Cell 1995; 83: 841-850.
-
(1995)
Cell
, vol.83
, pp. 841-850
-
-
Mangelsdorf, D.J.1
Evans, R.M.2
-
33
-
-
0030960780
-
Retinoic acid receptor/retinoid X receptor heterodimers can be activated through both subunits providing a basis for synergistic transactivation and cellular differentiation
-
Botling J et al. Retinoic acid receptor/retinoid X receptor heterodimers can be activated through both subunits providing a basis for synergistic transactivation and cellular differentiation. J Biol Chem 1997; 272: 9443-9449.
-
(1997)
J Biol Chem
, vol.272
, pp. 9443-9449
-
-
Botling, J.1
-
34
-
-
0029097177
-
Design and synthesis of potent retinoid X receptor selective ligands that induce apoptosis in leukaemia cells
-
Boehm MF et al. Design and synthesis of potent retinoid X receptor selective ligands that induce apoptosis in leukaemia cells. J Med Chem 1995; 38: 3146-3155.
-
(1995)
J Med Chem
, vol.38
, pp. 3146-3155
-
-
Boehm, M.F.1
-
35
-
-
13244267274
-
Acute promyelocytic leukemia: Recent advances in therapy and molecular basis to arsenic therapies
-
Chou WC, Dang CV. Acute promyelocytic leukemia: recent advances in therapy and molecular basis to arsenic therapies. Curr Opin Hematol 2005; 12: 1-6.
-
(2005)
Curr Opin Hematol
, vol.12
, pp. 1-6
-
-
Chou, W.C.1
Dang, C.V.2
-
36
-
-
0029862212
-
Cellular catabolism in apoptosis: DNA degradation and endonuclease activation
-
Montague JW, Cidlowski JA. Cellular catabolism in apoptosis: DNA degradation and endonuclease activation. Experientia 1996; 52: 957-962.
-
(1996)
Experientia
, vol.52
, pp. 957-962
-
-
Montague, J.W.1
Cidlowski, J.A.2
-
37
-
-
36049035359
-
Andrographolide inhibits human hepatoma-derived Hep3B cell growth through the activation of c-Jun N-terminal kinase
-
Ji L et al. Andrographolide inhibits human hepatoma-derived Hep3B cell growth through the activation of c-Jun N-terminal kinase. Planta Med 2007; 73(13): 1397-1401.
-
(2007)
Planta Med
, vol.73
, Issue.13
, pp. 1397-1401
-
-
Ji, L.1
-
38
-
-
45849148921
-
Anti-tumor activities of andrographolide, a diterpene from Andrographis paniculata, by inducing apoptosis and inhibiting VEGF level
-
Zhao F et al. Anti-tumor activities of andrographolide, a diterpene from Andrographis paniculata, by inducing apoptosis and inhibiting VEGF level. J Asian Nat Prod Res 2008; 10(5-6): 473-479.
-
(2008)
J Asian Nat Prod Res
, vol.10
, Issue.5-6
, pp. 473-479
-
-
Zhao, F.1
-
39
-
-
0030610687
-
3) in the treatment of acute promyelocytic leukemia (APL) II: Clinical efficacy and pharmacokinetics in relapsed patients
-
3) in the treatment of acute promyelocytic leukemia (APL) II: clinical efficacy and pharmacokinetics in relapsed patients. Blood 1997; 89(9): 3354-3360.
-
(1997)
Blood
, vol.89
, Issue.9
, pp. 3354-3360
-
-
Shen, Z.X.1
-
40
-
-
0033570955
-
Studies on the treatment of acute promyelocytic leukemia with arsenic trioxide: Remission induction, follow-up, and molecular monitoring in 11 newly diagnosed and 47 relapsed acute promyelocytic leukemia patients
-
Niu C et al. Studies on the treatment of acute promyelocytic leukemia with arsenic trioxide: remission induction, follow-up, and molecular monitoring in 11 newly diagnosed and 47 relapsed acute promyelocytic leukemia patients. Blood 1999; 94(10): 3315-3324.
-
(1999)
Blood
, vol.94
, Issue.10
, pp. 3315-3324
-
-
Niu, C.1
-
41
-
-
33846039899
-
Designed ATRA analogue active against ATRA-resistant acute promyelocytic leukemia cells having a single nucleotide substitution in their retinoic acid receptor
-
Komura N et al. Designed ATRA analogue active against ATRA-resistant acute promyelocytic leukemia cells having a single nucleotide substitution in their retinoic acid receptor. Leuk Res 2007; 31(3): 301-313.
-
(2007)
Leuk Res
, vol.31
, Issue.3
, pp. 301-313
-
-
Komura, N.1
-
42
-
-
36048998122
-
HSP90 inhibitor 17AAG causes apoptosis in ATRA-resistant acute promyelocytic leukemia cells
-
Meyer PN et al. HSP90 inhibitor 17AAG causes apoptosis in ATRA-resistant acute promyelocytic leukemia cells Leuk Res. 2008; 32(1): 143-149.
-
(2008)
Leuk Res
, vol.32
, Issue.1
, pp. 143-149
-
-
Meyer, P.N.1
-
43
-
-
0033846074
-
A phase I trial of andrographolide in HIV positive patients and normal volunteers
-
Calabrese C et al. A phase I trial of andrographolide in HIV positive patients and normal volunteers. Phytother Res 2000; 14(5): 333-338.
-
(2000)
Phytother Res
, vol.14
, Issue.5
, pp. 333-338
-
-
Calabrese, C.1
-
44
-
-
33746165562
-
Semisynthesis and cytotoxic activities of andrographolide analogues
-
Jada SR et al. Semisynthesis and cytotoxic activities of andrographolide analogues. J Enzyme Inhib Med Chem 2006: 21(2): 145-155.
-
(2006)
J Enzyme Inhib Med Chem
, vol.21
, Issue.2
, pp. 145-155
-
-
Jada, S.R.1
-
45
-
-
33847248975
-
Semisynthesis and in vitro anticancer activities of andrographolide analogues
-
Jada SR et al. Semisynthesis and in vitro anticancer activities of andrographolide analogues. Phytochemistry 2007; 68(6): 904-912.
-
(2007)
Phytochemistry
, vol.68
, Issue.6
, pp. 904-912
-
-
Jada, S.R.1
|